Chirurgia generale

Dupuytren: Non-Surgical Treatment

At present, the surgical approach is the only possible choice for Dupuytren’s disease, but FDA is evaluating the proposal of a therapy based on collagenase derived from Clostridium Histolyticum, injected in the local site. With a trial sponsored by pharmaceutical industry, 308 patients with Dupuytren’s disease have been randomized to receive a series of injections of collagenase or placebo.
Approfondisci

 http://mn.medsurfnews.com/contents/en/4908/display/dupuytren...

MedNews